Disclosure: This post was sponsored by Galderma Laboratories L.P. through their partnership with POPSUGAR.While I was compensated by POPSUGAR to write a post about Mirvaso, all opinions are my own.
As a professional makeup artist one of the top complaints I hear from clients is the frustration of dealing with rosacea, and its effect on their confidence. From attempting to cover up their redness with heavy camouflage cream, or experimenting with a multitude of products promising to cure all, patients are left exasperated.
That is when I refer my clients to MIRVASO (brimonidine) topical gel, 0.33%*, which aids in reducing and treating chronic rosacea, and excessive redness of the skin. Instead of simply masking the effects of rosacea, MIRVASO actually takes care of the problems associated with rosacea.
- In clinical studies with MIRVASO, the primary endpoint† showed rosacea redness was reduced for up to 12 hours for 22% of study participants (versus 9% of people using a gel with no active ingredient [vehicle gel]).
- The secondary endpoint† showed redness was visibly reduced in as little as 30 minutes for 28% of participants (versus 6% of people using the vehicle gel).
Although you may not be affected by rosacea, there may be someone you are close with who is suffering from excessive facial redness. This skin condition affects an estimated 16 million men and women in the United States. This amazing treatment hopes to help eliminate the problem.
This summer MIRVASO is asking you to support their challenge for rosacea patients to “Break Up With Your Makeup”, and finally be free from heavy, masking cover cream and makeup. To help support this cause simply enter their amazing sweepstakes that gives you a chance to win a trip to the Emmy’s in the fall! The ultimate celebrity event where you can walk the red carpet with confidence and show off your gorgeous skin (rosacea free!).
IMPROTANT SAFTEY INFORMATION:
- Indication: Mirvaso® (brimonidine) topical gel, 0.33% is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older.
- Adverse Events: In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin burning sensation and contact dermatitis.
- Warnings/Precautions: Mirvaso Gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud’s phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome. Alpha-2 adrenergic agents can lower blood pressure. Mirvaso Gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease. Serious adverse reactions following accidental ingestion of Mirvaso Gel by children have been reported.
- Keep Mirvaso Gel out of reach of children. Not for oral, ophthalmic, or intravaginal use. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Disclosure: This post was sponsored by Galderma Laboratories L.P. through their partnership with POPSUGAR. While I was compensated by POPSUGAR to write a post about Mirvaso, all opinions are my own.